Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1984 Feb 11;288(6415):439–441. doi: 10.1136/bmj.288.6415.439

Meningococcal septicaemia treated with combined plasmapheresis and leucapheresis or with blood exchange.

B Bjorvatn, L Bjertnaes, H O Fadnes, T Flaegstad, T J Gutteberg, B E Kristiansen, J Pape, O P Rekvig, B Osterud, L Aanderud
PMCID: PMC1444687  PMID: 6419956

Abstract

Mortality among patients suffering from meningococcal septicaemia has reached nearly 50% in parts of northern Norway despite intensive care. The activation of complement and blood cells by endotoxin is assumed to be the cause of most of the associated pathophysiological changes. Consequently, it would seem logical to remove such constituents either by combined plasmapheresis and leucapheresis or by blood exchange in patients with a fatal prognosis. Three patients were treated with plasmapheresis and leucapheresis and one with blood exchange. All recovered without sequelae, and no complications or serious problems caused by these procedures were observed. It is concluded that either combined leucapheresis and plasmapheresis or blood exchange is well tolerated and a valuable supplement to conventional intensive care in fulminant meningococcal septicaemia.

Full text

PDF
439

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berild D., Gedde-Dahl T. W., Abrahamsen T. Meningococcal disease in the Norwegian Armed Forces 1967-1979. Some epidemiological aspects. NIPH Ann. 1980 Dec;3(2):23–30. [PubMed] [Google Scholar]
  2. Brandslund I., Siersted H. C., Svehag S. E., Teisner B. Double-decker rocket immunoelectrophoresis for direct quantitation of complement C3 split products with C3d specificities in plasma. J Immunol Methods. 1981;44(1):63–71. doi: 10.1016/0022-1759(81)90107-1. [DOI] [PubMed] [Google Scholar]
  3. Bøvre K., Gedde-Dahl T. W. Epidemiological patterns of meningococcal disease in Norway 1975-1979. NIPH Ann. 1980 Dec;3(2):9–22. [PubMed] [Google Scholar]
  4. Harthug S., Bjorvatn B., Osterud B. Quantitation of endotoxin in blood from patients with meningococcal disease using a limulus lysate test in combination with chromogenic substrate. Infection. 1983 Jul-Aug;11(4):192–195. doi: 10.1007/BF01641194. [DOI] [PubMed] [Google Scholar]
  5. Jacob H. S. The role of activated complement and granulocytes in shock states and myocardial infarction. J Lab Clin Med. 1981 Nov;98(5):645–653. [PubMed] [Google Scholar]
  6. Osterud B., Eskeland T. The mandatory role of complement in the endotoxin-induced synthesis of tissue thromboplastin in blood monocytes. FEBS Lett. 1982 Nov 22;149(1):75–79. doi: 10.1016/0014-5793(82)81075-2. [DOI] [PubMed] [Google Scholar]
  7. Osterud B., Flaegstad T. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis. Thromb Haemost. 1983 Feb 28;49(1):5–7. [PubMed] [Google Scholar]
  8. Scharfman W. B., Tillotson J. R., Taft E. G., Wright E. Plasmapheresis for meningococcemia with disseminated intravascular coagulation. N Engl J Med. 1979 May 31;300(22):1277–1278. [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES